Description

Flixotid Nebuli (Fluticasone) Suspension 0.5 mg/2 ml – Pack of 10

Composition:

Each 2 ml of Flixotid Nebuli suspension contains 0.5 mg of fluticasone.

Mechanism of Action:

Fluticasone, a potent corticosteroid, exerts anti-inflammatory effects in the airways, reducing inflammation and improving lung function.

Pharmacological Properties:

Fluticasone acts locally in the lungs to reduce inflammation, swelling, and mucus production, leading to improved breathing and decreased asthma symptoms.

Indications for Use:

Flixotid Nebuli is indicated for the maintenance treatment of asthma as a prophylactic therapy in adults and children. It helps reduce airway inflammation, facilitating easier breathing.

Contraindications:

Avoid using Flixotid Nebuli if allergic to fluticasone or any other components. Not suitable for treating acute asthma attacks.

Side Effects:

Common side effects may include throat irritation, hoarseness, and oral thrush. Consult a healthcare provider if experiencing persistent side effects.

Usage Instructions:

Administer Flixotid Nebuli as directed by a healthcare professional via inhalation using a nebulizer. Rinse the mouth with water after each use to prevent oral complications.

Benefits Compared to Analogues:

Flixotid Nebuli offers effective asthma management with minimal systemic effects due to its local action in the lungs, making it a safe long-term treatment option.

Suitable Patient Groups:

Flixotid Nebuli is suitable for both children and elderly patients when prescribed by a healthcare provider based on individual needs and condition severity.

Storage and Shelf Life:

Store Flixotid Nebuli at room temperature away from moisture and sunlight. Check the expiration date on the packaging and do not use expired products.

Packaging Description:

Flixotid Nebuli is available in packs containing 10 single-dose vials of 2 ml suspension for inhalation.

Clinical Evidence and Effectiveness:

Studies have shown that regular use of fluticasone in Flixotid Nebuli significantly reduces asthma symptoms, improves lung function, and prevents exacerbations. Research published in the Journal of Allergy and Clinical Immunology supports the efficacy of fluticasone in managing airway inflammation and asthma control.